Nanosonics Secures FDA Approval to Launch Trophon3, Key Software Upgrade

MT Newswires Live
Aug 06

Nanosonics (ASX:NAN) has secured US Food and Drug Administration clearance to launch its trophon3 ultrasound disinfection system alongside a new software upgrade for existing trophon2 users, according to a Wednesday Australian bourse filing.

The trophon3 is set to deliver 40% faster disinfection, enhanced digital integration, and industry-leading traceability with new digital imaging and communications in medicine connectivity (DICOM), the filing said.

The launch will drive growth in hospitals and private practices and upgrade 10,000 original devices, while the trophon2 Plus upgrade targets 20,000 existing users, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10